Concentration of glycosaminoglycan in ovariectomized mice uterus after treatment with ovarian steroids

Concentration of glycosaminoglycan in ovariectomized mice uterus after treatment with ovarian steroids

Autor Maioral, Gabriela C. C. C. Autor UNIFESP Google Scholar
Gomes, Regina Celia T. Autor UNIFESP Google Scholar
Verna, Carina Autor UNIFESP Google Scholar
Simoes, Manuel de J. Autor UNIFESP Google Scholar
Nader, Helena B. Autor UNIFESP Google Scholar
Simoes, Ricardo S. Google Scholar
Baracat, Edmund C. Google Scholar
Soares-, Jose Maria, Jr. Google Scholar
Resumo The aim of this study was to evaluate the amount of non-and sulfated glycosaminoglycans in the ovariectomized mice uterus, after treatment with ovarian steroids. For this purpose, 50 adult female mice were divided into five groups with 10 animals/each: control group: CG (ovary intact), and ovariectomized groups: OG (vehicle), EG (estradiol), PG (progesterone) and EPG (estradiol combined to progesterone). The treatments started 30 days after ovariectomy. All the animals were treated for 50 consecutive days. These hormones were administered in a sterile oily solution via gavage. Twenty-four hours after the last treatment, all animals were euthanized, removing the uterine horn for biochemical analyses. To quantify, the hyaluronic acid (HA) used ELISA-like fluorometric assay, and the sulfated glycosaminoglycans (GAGs) used agarose gel electrophoresis. The amount of HA was significantly higher in the group treated with progesterone (PG) compared to the others groups (p < 0.05), and in the group treated with estradiol (EG), the amount of chondroitin/dermatan sulfate was significantly higher compared to the others groups (p < 0.05), and in the group treated with progesterone (PG), the amount of heparan sulfate was significantly lower compared to the others groups, except to control group (p < 0.05). Our results showed that the estroprogestative therapy after long time (50 days) profoundly affected the amount of glycosaminoglycans in uterine. These changes may be indicative of uterine pathology such as the development of tumor.
Assunto Hyaluronic Acid
Ovarian Steroids
Sulfated GlycosaminoglycansExtracellular-Matrix
Human Endometrium
Heparan-Sulfate
Mouse
Proteoglycans
Progesterone
Hyaluronan
Estrogen
Expression
Estradiol
Idioma Inglês
Financiador Foundation for Research Support of Sao Paulo (FAPESP) [2009/52758-9]
Número do financiamento FAPESP: 2009/52758-9
Data 2016
Publicado em Gynecological Endocrinology. Abingdon, v. 32, n. 8, p. 617-621, 2016.
ISSN 0951-3590 (Sherpa/Romeo, fator de impacto)
Editor Hindawi Publishing Corp
Extensão 617-621
Fonte https://doi.org/10.3109/09513590.2016.1147027
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000387480900008
URI http://repositorio.unifesp.br/handle/11600/49361

Mostrar registro completo




Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)